Rasagiline reduces disability for patients with advanced Parkinson...( This release is also available in Ge...)

Rasagiline reduces disability for patients with advanced Parkinson's disease

This release is also available in German.

Giving Parkinson's patients on levodopa treatment an additional drug called rasagiline once daily can improve their motor function, concludes a study published in this week's issue of THE LANCET.

Most patients with established Parkinson's disease receiving long-term treatment with levodopa will eventually have motor fluctuations, defined as periods of the day with poor or absent motor response to their medication (off-time) alternating with periods of clearly improved motor function (on-time). Several drugs (pergolide, pramipexole, ropinirole, entacapone and tolcapone) when added to levodopa have been effective in the management of fluctuations but these drugs only provide partial improvement, leaving patients with clinically significant off-periods, while adding complexity to the treatment schedule. Preliminary data shows that the additional use of rasagiline may be useful in the treatment of advanced Parkinson's disease.

Olivier Rascol (University Hospital, Toulouse, France) and colleagues recruited 687 patients from 74 hospitals and centres in Israel, Argentina, and Europe. 231 individuals were assigned to receive 1mg of oral rasagiline once daily, 227 to entacapone (200mg with every levodopa dose) and 229 to a placebo. Both rasagiline and entacapone reduced average daily off-time (-1.18 hours for rasagiline and V1.2 hours for entacapone) when compared with placebo. Rasagiline had a safety profile similar to that of the placebo and its once daily regimen was convenient to administer. The drug was well tolerated in the old-age group (d70).

Professor Rascol states: "This study has shown that rasagiline is an effective, safe and simple treatment for Parkinson's disease when used in combination with levodopa. Rasagiline achieved the two main goals of treatment after levodopa -- reduced disability and decreased motor f
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
10-Mar-2005

Page: 1 2
Related medicine news :

1. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints
2. Targeting mutant B-Raf protein reduces melanoma development
3. Breast cancer treatment reduces risk of heart disease
4. Carrot component reduces cancer risk
5. Sex hormone metabolite reduces stress, anxiety in female rats
6. Sunlight reduces risk of lymph gland cancer
7. Male circumcision reduces risk of HIV transmission from women to men
8. Surgical treatment of migraines reduces sick days and increases employee productivity ASPS study
9. Novel p53 gene-based therapy boosts immune system and reduces tumor size
10. VGTI researchers help uncover why aging reduces immune system function
11. Early detection reduces threat of foot injury in college basketball players

Post Your Comments:

(Date:11/23/2009)... Women who store fat on their waist in middle age ...when they get older, reveals a new study from the ...ublished in the scientific journal Neurology . ,...is at greater risk of dying prematurely due to a h...nior lecturer at the Sahlgrenska Academy. "If they...

(Date:11/23/2009)... Augusta, Ga. - The Medical College of Georgia is ...igm shift in the care of patients with sickle cell...cine and University of Florida are partners in the...ans across Georgia to serve as "medical homes" for...a pain crisis sends them to the hospital and seeki...

(Date:11/23/2009)... Life-Science Focused Stra... of Marketing and Communication Professionals , ...23, 2009 -- LaVoie Group, a life science-focused s...at it has received the 2009 MarCom Gold Award in t...nd judged by the Association of Marketing and Comm...

(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire-FirstCall/--AnnTa...thisyearasapartnerforthe6thannualThanksandGivingca....JudeChildren,sResearchHospital.Thisyearmarkstheth...ivinginitiative,hasparticipatedinthecampaignwherew...livesbysupportingSt.Judewhileshoppingthisholidayse...

(Date:11/23/2009)..., KANSASCITY,Mo.,Nov.23/PRNewswire/--Christin...rgestprivatelyownedinsurancebrokerage.Hoehnewillse...nefitServices practiceinLockton,s Minneapolis offi...nh/20090415/CG99351LOGO ) ,, "Wearethrilledtoha...ocktonInternationalBenefitServices."Shebroadensour...

Breaking Medicine News(10 mins):Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2 Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3 Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4 Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5 Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2 Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3 Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2 Health News:Lockton Benefit Group Expands International Benefit Team 2

[0] Fat around the middle increases the risk of dementia [0] Initiative could result in paradigm shift in the care of sickle cell patients [0] LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign [0] Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year [0] Lockton Benefit Group Expands International Benefit Team

(Date:11/23/2009)...eFDAapprovalsoftwonewtherapiesforNon-Hodgkin,sLymp...oincludeofatumumab(Azerra(TM),GlaxoSmithKline)asat...mia(CLL)andromidepsin(Istodax(R),GloucesterPharmac...eousT-celllymphoma(CTCL). ,, FORTWASHINGTON,Pa....alshavepromptedtheNationalComprehensiveCancerNetwo...

(Date:11/23/2009)....23/PRNewswire/--Reportlinker.comannouncesthatanew..., HolterMonitoringSystems-AGlobalMarketReview ,...-Monitoring-Systems---A-Global-Market-Review.html#...mpaign=prnewswire ,, Cardiovascularmonitori...kpatientsneedtobecontinuouslymonitoredduringdiagno...

(Date:11/23/2009)...,Nov.23/PRNewswire/--BridgePointMedicalannouncedto...e)foritscoronaryandperipheralChronicTotalOcclusion...rossingCatheterandtheStingray®CTORe-EntrySyst...thetersthataredesignedtonavigatehighlydiseasedarte...astyandstenting. ,, TheNationalHeart,LungandBlo...

Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2 NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3 Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2 Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3 Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4 Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5 BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2 Sirnaomics Receives SBIR Grant from NIH NCI for Its Multi Targeted Lung Cancer siRNA Therapeutics 13154 1 Sirnaomics Receives SBIR Grant from NIH NCI for Its Multi Targeted Lung Cancer siRNA Therapeutics 13154 2 Sirnaomics Receives SBIR Grant from NIH NCI for Its Multi Targeted Lung Cancer siRNA Therapeutics 13154 3 Many Young Adults Uninformed About Vaccines 52443 1 Many Young Adults Uninformed About Vaccines 52443 2 Many Young Adults Uninformed About Vaccines 52443 3 SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 1 SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 2 SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 3 SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 4

[0] NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options [0] Reportlinker Adds Holter Monitoring Systems - A Global Market Review [0] BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries

Other News:

...ANCISCO The muscle supplement creatine can be saf... but does not improve strength or muscle mass, acc...merican Academy of Neurology 56th Annual Meeting i......Creatine stores energy within muscles, and crea...

...ANCISCO One variant of the apolipoprotein E (APOE...e, according to an analysis of research that will ...56th Annual Meeting in San Francisco, Calif., Apri... or alleles, called 2, 3 and 4. The APOE-2 form of...

...ND, Ore. The rate of brain volume loss may help d...ntia before they even start showing signs of the d...hers discovered.......Scientists at the Layton Cen...e OHSU School of Medicine's Department of Neurolog...

...a drug suffused in promise, a next-generation ther... Iressa is the kind of treatment that oncologists ..., a non-toxic therapy that causes few side effects...ople who have no other options left for them, Ires...

Creatine is safe, but not effective, in pediatric neuromuscular disease APOE gene linked to Parkinson's disease OHSU study: Rate of brain volume loss predicts dementia Iressa news backgrounder: Testing of smart drug expands at M. D. Anderson Cancer Center

...r critical care services in the United States will... intensive care a situation that, if not remedied... solution to this problem lies not in recruiting a...e critical care system nationwide, according to a ...

...on an international team of scientists stationed ...ng the North Pole on foot. Both teams, however, ar...al data on the ground and from the air in support ...ission, due for launch in 2009, will provide highl...

... paper and principles assuring that physicians are...atings that they believe are inaccurate were adopt... (ACP) at its annual meeting. The principles, pa...Which Physicians Participating in Performance Meas...

...ls conducting clinical trials should provide more ...before they talk to patients about participating i...ns of a new survey by researchers from Duke Univer...Their study found that 41 percent of the clinical ...

health news:US critical care delivery system in critical condition 2 health news:US critical care delivery system in critical condition 3 health news:Scientists and polar explorers brave the elements in support of CryoSat-2 2 health news:Scientists and polar explorers brave the elements in support of CryoSat-2 3 health news:Physicians should be able to review performance rates before release 2 health news:Physicians should be able to review performance rates before release 3 health news:Physicians should be able to review performance rates before release 4 health news:Clinical trial coordinators need more financial conflict-of-interest training 2 health news:Clinical trial coordinators need more financial conflict-of-interest training 3

US critical care delivery system in critical condition Scientists and polar explorers brave the elements in support of CryoSat-2 Physicians should be able to review performance rates before release Clinical trial coordinators need more financial conflict-of-interest training

Rasagiline reduces disability for patients with advanced Parkinson...( This release is also available in Ge...),Health